X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (34418) 34418
Publication (2185) 2185
Book Review (491) 491
Newsletter (283) 283
Book Chapter (106) 106
Magazine Article (80) 80
Conference Proceeding (69) 69
Book / eBook (43) 43
Transcript (12) 12
Newspaper Article (11) 11
Dissertation (5) 5
Reference (5) 5
Trade Publication Article (5) 5
Web Resource (5) 5
Data Set (3) 3
Government Document (3) 3
Paper (3) 3
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (31458) 31458
immunosuppressive agents - adverse effects (18539) 18539
male (17853) 17853
female (17372) 17372
immunosuppressive agents - therapeutic use (16840) 16840
index medicus (13424) 13424
adult (13175) 13175
middle aged (12759) 12759
transplantation (9732) 9732
treatment outcome (7339) 7339
immunosuppressive agents - administration & dosage (6669) 6669
surgery (6097) 6097
aged (5980) 5980
immunology (5722) 5722
risk factors (4782) 4782
adolescent (4773) 4773
immunosuppressive agents (4279) 4279
retrospective studies (4227) 4227
time factors (4130) 4130
animals (3936) 3936
kidney transplantation (3804) 3804
child (3697) 3697
drug therapy, combination (3647) 3647
therapy (3418) 3418
immunosuppression (3394) 3394
kidney transplantation - adverse effects (3351) 3351
cyclosporine - adverse effects (3306) 3306
cyclosporine (3268) 3268
follow-up studies (3001) 3001
graft rejection - prevention & control (2964) 2964
cyclosporine - therapeutic use (2870) 2870
tacrolimus (2771) 2771
recipients (2694) 2694
young adult (2491) 2491
tacrolimus - adverse effects (2314) 2314
tacrolimus - therapeutic use (2182) 2182
health aspects (2167) 2167
care and treatment (2166) 2166
kidney transplantation - immunology (2154) 2154
pharmacology & pharmacy (2130) 2130
mycophenolic acid - analogs & derivatives (2126) 2126
immunosuppressive agents - pharmacology (2104) 2104
urology & nephrology (2038) 2038
gastroenterology & hepatology (2018) 2018
kidneys (1957) 1957
child, preschool (1919) 1919
prospective studies (1892) 1892
disease (1885) 1885
immunotherapy (1870) 1870
hematology (1848) 1848
transplantation, homologous (1832) 1832
drug therapy (1731) 1731
medicine, general & internal (1728) 1728
rheumatology (1680) 1680
research (1673) 1673
dermatology (1655) 1655
azathioprine - therapeutic use (1619) 1619
mycophenolic acid - therapeutic use (1611) 1611
recurrence (1592) 1592
oncology (1539) 1539
incidence (1526) 1526
immunocompromised host (1522) 1522
analysis (1520) 1520
biopsy (1518) 1518
graft rejection - immunology (1503) 1503
dose-response relationship, drug (1502) 1502
azathioprine - adverse effects (1441) 1441
liver transplantation (1431) 1431
graft survival (1425) 1425
antibodies, monoclonal - therapeutic use (1412) 1412
mycophenolate-mofetil (1401) 1401
azathioprine (1394) 1394
cyclosporine - administration & dosage (1387) 1387
pediatrics (1387) 1387
calcineurin inhibitors (1381) 1381
children (1353) 1353
risk (1347) 1347
liver transplantation - adverse effects (1340) 1340
prognosis (1322) 1322
drug administration schedule (1309) 1309
renal-transplantation (1277) 1277
tacrolimus - administration & dosage (1277) 1277
medicine & public health (1272) 1272
infection (1262) 1262
organ transplant recipients (1258) 1258
immunosuppressive agents - pharmacokinetics (1255) 1255
efficacy (1235) 1235
liver (1213) 1213
corticosteroids (1212) 1212
patients (1208) 1208
sirolimus - therapeutic use (1183) 1183
graft rejection (1177) 1177
diagnosis (1171) 1171
infant (1160) 1160
cancer (1157) 1157
sirolimus (1157) 1157
mycophenolic acid - adverse effects (1149) 1149
abridged index medicus (1122) 1122
safety (1120) 1120
sirolimus - adverse effects (1114) 1114
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (28) 28
Online Resources - Online (7) 7
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Gerstein Science - Periodical Stacks (1) 1
Trinity College (John W Graham) - Storage (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (31591) 31591
German (844) 844
French (697) 697
Spanish (512) 512
Japanese (383) 383
Chinese (157) 157
Italian (134) 134
Russian (117) 117
Polish (102) 102
Hungarian (62) 62
Dutch (49) 49
Danish (47) 47
Portuguese (37) 37
Norwegian (35) 35
Czech (34) 34
Croatian (22) 22
Swedish (19) 19
Hebrew (17) 17
Finnish (15) 15
Korean (12) 12
Serbian (9) 9
Bulgarian (8) 8
Romanian (7) 7
Lithuanian (5) 5
Turkish (5) 5
Slovak (3) 3
Icelandic (2) 2
Bosnian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Hepatology, ISSN 0168-8278, 2012, Volume 58, Issue 4, pp. 792 - 800
Summary Hepatitis C virus (HCV) infected patients often take multiple co-medications to treat adverse events related to HCV therapy, or to manage other... 
Gastroenterology and Hepatology | Boceprevir | Hepatitis C virus infection | Telaprevir | Pharmacokinetics | Drug interactions | CHRONIC HEPATITIS-C | GASTROENTEROLOGY & HEPATOLOGY | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Hepatitis C, Chronic - metabolism | Antiviral Agents - pharmacokinetics | Hypnotics and Sedatives - adverse effects | Humans | Hypnotics and Sedatives - administration & dosage | Drug Interactions | Hypoglycemic Agents - administration & dosage | Drug Therapy, Combination | Immunosuppressive Agents - administration & dosage | Cardiovascular Agents - administration & dosage | Anti-Infective Agents - adverse effects | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Opiate Substitution Treatment - adverse effects | Buprenorphine - administration & dosage | Anti-Infective Agents - administration & dosage | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Antiviral Agents - adverse effects | Buprenorphine - adverse effects | Antidepressive Agents - administration & dosage | Immunosuppressive Agents - adverse effects | Methadone - administration & dosage | Methadone - adverse effects | Antidepressive Agents - adverse effects | Cardiovascular Agents - adverse effects | Hypoglycemic Agents - adverse effects | Hepatitis C virus
Journal Article
Journal Article
American Journal of Gastroenterology, ISSN 0002-9270, 01/2013, Volume 108, Issue 1, pp. 99 - 105
OBJECTIVES: The risk of non-Hodgkin's lymphoma (NHL) with tumor necrosis factor alpha (TNF-alpha) inhibitors is unclear, whether related to concomitant... 
RHEUMATOID-ARTHRITIS | INFLAMMATORY-BOWEL-DISEASE | THERAPY | AZATHIOPRINE | RISK | INFLIXIMAB | GASTROENTEROLOGY & HEPATOLOGY | CANCER | MEDLINE | Azathioprine - therapeutic use | Lymphoma, T-Cell - chemically induced | Certolizumab Pegol | United States | Humans | Immunoglobulin Fab Fragments - adverse effects | Immunosuppressive Agents - therapeutic use | Middle Aged | Antibodies, Monoclonal - adverse effects | Polyethylene Glycols - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Immunoglobulin Fab Fragments - therapeutic use | Polyethylene Glycols - therapeutic use | Receptors, Tumor Necrosis Factor - therapeutic use | Etanercept | Infliximab | Arthritis, Rheumatoid - drug therapy | Mercaptopurine - therapeutic use | Aged, 80 and over | Adult | Female | Drug Therapy, Combination | Odds Ratio | United States Food and Drug Administration | Inflammatory Bowel Diseases - drug therapy | Antibodies, Monoclonal, Humanized - adverse effects | SEER Program | Antibodies, Monoclonal, Humanized - therapeutic use | Psoriasis - drug therapy | Adverse Drug Reaction Reporting Systems | Risk Factors | Spondylitis, Ankylosing - drug therapy | Mercaptopurine - adverse effects | Immunoglobulin G - therapeutic use | Immunoglobulin G - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Immunosuppressive Agents - adverse effects | Aged | Adalimumab | Azathioprine - adverse effects | Tumor Necrosis Factor-alpha - antagonists & inhibitors
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2011, Volume 365, Issue 20, pp. 1886 - 1895
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2013, Volume 19, Issue 1, pp. 117 - 122
Abstract Fifty patients with high-risk hematologic malignancies, underwent an unmanipulated haploidentical bone marrow transplantation (BMT), followed by... 
Hematology, Oncology and Palliative Medicine | Haploidentical transplantations | Acute leukemia | HLA | Posttransplantation cyclophosphamide | Allogeneic stem cell transplant | MORTALITY | IMMUNOLOGY | RECIPIENTS | VERSUS-HOST-DISEASE | TRANSPLANTATION | REDUCED-INTENSITY | ACUTE-LEUKEMIA | HIGH-RISK | HAPLOTYPE | OUTCOMES | STEM-CELL TRANSPLANTATION | HEMATOLOGY | BLOOD | Hematologic Neoplasms - therapy | Whole-Body Irradiation | Cyclophosphamide - administration & dosage | Follow-Up Studies | Myeloablative Agonists - adverse effects | Thiotepa - administration & dosage | Hematologic Neoplasms - mortality | Humans | Middle Aged | Male | Antineoplastic Agents - administration & dosage | Busulfan - administration & dosage | Cyclophosphamide - adverse effects | Transplantation, Homologous | Graft vs Host Disease - mortality | Antineoplastic Agents - adverse effects | Bone Marrow Transplantation | Adult | Female | Retrospective Studies | Graft vs Host Disease - etiology | Immunosuppressive Agents - administration & dosage | Acute Disease | Busulfan - adverse effects | Vidarabine - adverse effects | Survival Rate | Vidarabine - analogs & derivatives | Disease-Free Survival | Adolescent | Myeloablative Agonists - administration & dosage | Graft vs Host Disease - prevention & control | Immunosuppressive Agents - adverse effects | Aged | Vidarabine - administration & dosage | Transplantation Conditioning | Chronic Disease | Thiotepa - adverse effects | Antimitotic agents | Pneumonia | Cyclophosphamide | Bacterial pneumonia | Mortality | Bone marrow | Transplantation | Antineoplastic agents | Cancer
Journal Article
Lancet, The, ISSN 0140-6736, 11/2012, Volume 380, Issue 9856, pp. 1829 - 1839
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2013, Volume 369, Issue 5, pp. 417 - 427
This study of ANCA-associated vasculitis compared a single course of rituximab with conventional immunosuppression with cyclophosphamide followed by... 
WEGENERS-GRANULOMATOSIS | MAINTENANCE | MEDICINE, GENERAL & INTERNAL | ANTIBODY-ASSOCIATED VASCULITIS | RENAL VASCULITIS | CYCLOPHOSPHAMIDE | RITUXIMAB | ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES | RANDOMIZED-TRIAL | SYSTEMIC VASCULITIDES | CELL-ACTIVATION | Recurrence | Azathioprine - therapeutic use | Glucocorticoids - therapeutic use | Double-Blind Method | Drug Administration Schedule | Humans | Immunosuppressive Agents - therapeutic use | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Immunologic Factors - administration & dosage | Kaplan-Meier Estimate | B-Lymphocytes | Rituximab | Cyclophosphamide - adverse effects | Remission Induction | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - drug therapy | Cyclophosphamide - therapeutic use | Immunosuppressive Agents - adverse effects | Immunologic Factors - adverse effects | Drug Therapy, Combination | Antibodies, Monoclonal, Murine-Derived - adverse effects | Azathioprine - adverse effects | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Immunologic Factors - therapeutic use | Immunosuppression | Vasculitis | Drug therapy | Patient outcomes | Disease | Medical treatment | Hypersensitivity | Patients | Immunosuppressive agents | Cyclophosphamide | Infectious diseases | Lymphocytes B | Antineutrophil cytoplasmic antibodies | Remission | Azathioprine
Journal Article